Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors
NCT00112892
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DIETARY_SUPPLEMENT:
selenium
DRUG:
irinotecan hydrochloride
Sponsor
Roswell Park Cancer Institute